HC Q news
See all studies
2/17
Positive
Late treatment study
Sun Yanrong, deputy head of the China National Center for Biotechnology Development (News) (not included in the study count)
Antimalarial drug confirmed effective on COVID-19
HC Q under clinical trials in >10 hospitals in China and has shown fairly good efficacy. Currently no formal study is available so this is not included in the study count.
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments.
Submit